Trials / Unknown
UnknownNCT00804752
Vitamin D Treatment in Patients With Chronic Hepatitis C
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
We hypothesize that patients with Ch.HCV have a low level of vitamin D, and that by raising their vitamin D levels by adding it to their standard treament of Pegylated Interferon and Ribavirin, there will be an increase in their sustained virological response.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Adding vitamin D | Adding 1000IU/Vitamin D daily |
| DRUG | Vitamin D | Addition of 1000IU/day Vitamin D |
Timeline
- First posted
- 2008-12-09
- Last updated
- 2008-12-09
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00804752. Inclusion in this directory is not an endorsement.